RARS1 and acute promyelocytic leukemia: It is an effective agent for preventing cancer and treating skin diseases and acute promyelocytic leukemia (APL). Its pharmacological effects are mainly mediated by retinoid X receptors (RXRs) and retinoic acid receptors (RARs) [81].